“Fondaparinux - 7.5 mg/0.6 ml”

This tender is for the procurement of 'Fondaparinux - 7.5 mg/0.6 ml'. The specified pharmaceutical code is B01AX05, which corresponds to Fondaparinux, an anticoagulant medication. The form is a solution for injection, with each unit containing 7.5 mg of the active substance in 0.6 ml. The tender specifies the supply of 20 ampoules. Fondaparinux is a synthetic pentasaccharide that acts as a potent and selective indirect inhibitor of Factor Xa, a crucial enzyme in the blood coagulation cascade. It is used for the prevention and treatment of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE). This procurement aims to ensure the availability of this essential medication for patient care within the healthcare system.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums, with an estimated budget of BGN 385.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.